Robert Dunn Buys 105,000 Shares of DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn bought 105,000 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The shares were purchased at an average cost of C$0.48 per share, for a total transaction of C$50,400.00. Following the completion of the transaction, the director owned 2,679,920 shares of the company’s stock, valued at C$1,286,361.60. This represents a 4.08% increase in their ownership of the stock.

Robert Dunn also recently made the following trade(s):

• On Wednesday, July 29th, Robert Dunn purchased 200,000 shares of DIAGNOS stock. The stock was purchased at an average cost of C$0.30 per share, with a total value of C$60,000.00.

DIAGNOS Stock Up 2.0%

ADK opened at C$0.50 on Friday. DIAGNOS Inc. has a fifty-two week low of C$0.17 and a fifty-two week high of C$0.52. The company has a debt-to-equity ratio of 204.05, a current ratio of 1.49 and a quick ratio of 0.68. The firm’s fifty day moving average price is C$0.30 and its two-hundred day moving average price is C$0.27. The company has a market capitalization of C$60.21 million, a P/E ratio of -12.50 and a beta of -0.14.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.